M.P.G. Broen

van Hout, L., Borgo, A. D., Grun, N., Schuur, M., Broen, M. P. G., Westerman, B. A., Bartelink, I., Vandertop, W. P., Witte, B., & Kouwenhoven, M. C. M. (2025). Severe temozolomide-induced thrombocytopenia is linked to increased healthcare utilization in glioblastoma and disproportionally impacts female patients. Neuro-Oncology Practice, Article npaf013. https://doi.org/10.1093/nop/npaf013

Hamulyák, E. N., Wang, T.-F., Kreuziger, L. B., Iyengar, V., Carney, B. J., Hoeben, A., Özdemir, B. C., Serrano, R. D. C., Sanfilippo, K. M., Rozenblatt, S., Beenen, L. F. M., Yust-Katz, S., Halperin, E., Arad, A., Lubetsky, A., Carrier, M., Massat, B., Büller, H. R., Spectre, G., ... ten Cate, H. (2025). Multinational cohort study of intracranial hemorrhage in patients with brain metastases receiving anticoagulation. Haematologica-the Hematology Journal. Advance online publication. https://doi.org/10.3324/haematol.2024.286973

Angoumis, K., Padilla, C. S., Kouwenhoven, M. C. M., Bijlsma, R. M., Kaal, S. E. J., Tromp, J. M., Bos, M. E. M. M., van der Hulle, T., Broen, M. P. G., Nuver, J., van der Graaf, W. T. A., Pauge, S., & Husson, O. (2025). Adverse health outcomes and health-related quality of life (HRQoL) among long-term adolescent and young adult (AYA) brain tumour survivors: results from the population-based SURVAYA study. Supportive Care in Cancer, 33(2), Article 95. https://doi.org/10.1007/s00520-025-09155-9

Sanchez-Castillo, A., Savelkouls, K. G., Baldini, A., Hounjet, J., Sonveaux, P., Verstraete, P., De Keersmaecker, K., Dewaele, B., Bjorkblom, B., Melin, B., Wu, W. Y., Sjoberg, R. L., Rouschop, K. M. A., Broen, M. P. G., Vooijs, M., & Kampen, K. R. (2024). Sertraline/chloroquine combination therapy to target hypoxic and immunosuppressive serine/glycine synthesis-dependent glioblastomas. Oncogenesis, 13(1), Article 39. https://doi.org/10.1038/s41389-024-00540-3

Yang, C., Alvarado, D., Ravindran, P. K., Keizer, M. E., Hovinga, K., Broen, M. P. G., Kunst, H. P. M., & Temel, Y. (2024). Untreated Vestibular Schwannoma: Analysis of the Determinants of Growth. Cancers, 16(21), Article 3718. https://doi.org/10.3390/cancers16213718

Lionarons, J. M., Delespaul, P. A. E. G., Hellebrekers, D. M. J., Broen, M. P. G., Klinkenberg, S., Faber, C. G., Hendriksen, J. G. M., & Vles, J. S. H. (2024). Use of the experience sampling method in adolescents with Duchenne muscular dystrophy: a feasibility study. European Child & Adolescent Psychiatry, 33(7), 2281-2290. https://doi.org/10.1007/s00787-023-02317-2

Jacquerie, A., Hoeben, A., Eekers, D. B. P., Postma, A. A., Vanmechelen, M., de Smet, F., Ackermans, L., Anten, M., Severens, K., zur Hausen, A., Broen, M. P. G., & Beckervordersandforth, J. (2024). Prognostic relevance of high expression of kynurenine pathway markers in glioblastoma. Scientific Reports, 14(1), Article 14975. https://doi.org/10.1038/s41598-024-65907-3

Acem, I., Steyerberg, E. W., Spreafico, M., Gruenhagen, D. J., Callegaro, D., Spinner, R. J., Pendleton, C., Coert, J. H., Miceli, R., Abruzzese, G., Flucke, U. E., Slooff, W.-B. M., van Dalen, T., Been, L. B., Bonenkamp, H. J., Anten, M. H. M. E., Broen, M. P. G., Bemelmans, M. H. A., Bramer, J. A. M., ... Martin, E. (2024). Survival after resection of malignant peripheral nerve sheath tumors: Introducing and validating a novel type-specific prognostic model. Neuro-Oncology Advances, 6(1), Article vdae083. https://doi.org/10.1093/noajnl/vdae083

Birimac, N. E., Willems, Y. C. P., Zegers, C. M. L., Vaassen, F., Hofstede, D., Compter, I., Jaspers, J., Romero, A. M., Broen, M. P. G., Swinnen, A., Schijns, O. E. M. G., Unipan, M., Houben, R. M., van Elmpt, W., & Eekers, D. B. P. (2024). The existence of cranial bone flap displacement during brain radiotherapy. Technical Innovations and Patient Support in Radiation Oncology, 30, Article 100250. https://doi.org/10.1016/j.tipsro.2024.100250

Schoenmaekers, J., Dijkstra, J., van der Wekken, A., Paats, M., Broen, M., Brandts, L., Dingemans, A. M., & Hendriks, L. (2024). In-depth Analysis of Lorlatinib-related neurocognitive Adverse Events in Patients With Non–small-cell Lung Cancer. Clinical Lung Cancer, 25(2), 168-174.e1. https://doi.org/10.1016/j.cllc.2023.12.003